Research shows that routine blood tests cannot reliably predict who will develop weak bones or osteoporosis, according to a 2026 study of 2,147 patients. Gram Research analysis found that none of 20 blood markers tested could forecast bone loss, even though doctors often order these tests hoping to identify at-risk patients early. Bone density scans remain the most useful tool for assessing bone health and predicting progression.
Researchers followed over 2,000 people getting bone density scans to see if common blood tests could predict who would develop weak bones. According to Gram Research analysis, none of the standard blood markers tested were useful for forecasting bone loss or osteoporosis development. The study found that a person’s starting bone density category mattered more than any blood test result. While this is disappointing news for doctors hoping for an easy prediction tool, it highlights the need for better research methods that track treatments and bone changes over time.
Key Statistics
A 2026 retrospective cohort study of 2,147 patients found that none of 20 routine blood markers could predict bone loss or osteoporosis development after statistical correction for multiple testing.
During the study period, 107 out of 789 patients without osteoporosis at baseline developed the condition at a rate of 5.2 new cases per 100 people per year, but blood test results could not identify which patients would be affected.
Among 124 patients with normal baseline bone density, zero developed osteoporosis during follow-up, compared with 107 cases among 665 patients with baseline low bone density, though this difference did not reach statistical significance after correction.
The study tested time-by-biomarker interactions using linear mixed-effects models with Benjamini-Hochberg correction, and the smallest corrected p-value was 0.214, indicating no blood marker showed clinical utility for predicting bone density trajectories.
The Quick Take
- What they studied: Can routine blood tests predict whether someone’s bones will get weaker over time or develop osteoporosis?
- Who participated: 2,147 patients from a Saudi medical center who had bone density scans between 2016 and 2021. Most had at least two scans taken at least one year apart.
- Key finding: None of the 20 blood markers tested could reliably predict bone loss or osteoporosis development. During the study period, 107 out of 789 people without osteoporosis at the start developed it, but blood tests couldn’t identify who would be affected.
- What it means for you: If your doctor orders blood tests to predict your bone health, those results alone won’t tell you whether your bones will weaken. Your current bone density scan results matter more. Talk to your doctor about other ways to assess your bone health risk, such as your age, family history, and lifestyle factors.
The Research Details
This was a retrospective cohort study, meaning researchers looked back at medical records and bone scans that had already been done. They included 2,147 patients who had gotten bone density scans (called DXA scans) at a hospital in Saudi Arabia between 2016 and 2021. For the main analysis, they focused on 789 people who didn’t have osteoporosis when they started but were followed to see if they developed it.
The researchers used two statistical approaches. First, they looked at how bone density changed over time in relation to 20 different blood markers, using a method called linear mixed-effects modeling. Second, they used Cox regression analysis to see which blood markers could predict who would develop osteoporosis during the follow-up period. They were careful to correct for the fact that they were testing many markers at once, which can lead to false positives.
The study tracked patients for an average of about 2,045 person-years of observation. This means if you multiply the number of people by how long each was followed, you get this total. During this time, 107 people developed osteoporosis, which equals about 5.2 new cases per 100 people per year.
This research approach is important because it reflects real-world clinical practice. Doctors regularly order blood tests and bone density scans, and they want to know if simple blood work can help predict who will develop bone problems. By carefully tracking what actually happened in a large group of patients over several years, the researchers could test whether common blood markers have practical value. The study’s strength is that it used actual patient data rather than laboratory experiments.
This study has both strengths and limitations. The strength is the large sample size of over 2,000 patients followed over multiple years, which gives confidence in the findings. However, the researchers note several important limitations. They didn’t have complete information about whether patients were taking bone-strengthening medications, which could affect the results. They also didn’t know the exact timing of menopause for women, which is important for bone health. The study was done in one hospital in Saudi Arabia, so the results may not apply to other populations. Because this is a retrospective study looking at old records, the researchers couldn’t control all the factors that might influence bone health.
What the Results Show
The main finding was striking: none of the 20 blood markers tested showed statistical significance in predicting bone loss or osteoporosis development after the researchers corrected for testing multiple markers. This means that even though some blood tests might have looked promising at first glance, they didn’t hold up when properly analyzed.
During the study period, 107 people out of 789 who started without osteoporosis developed it over an average follow-up of about 2.6 years. This happened at a rate of 5.2 new cases per 100 people per year. Interestingly, among 124 people who had normal bone density at the start, none developed osteoporosis during the study. In contrast, among 665 people who started with low bone density (osteopenia), 107 developed full osteoporosis.
The researchers tested whether baseline bone density category could predict progression, but even this didn’t reach statistical significance after correction for multiple testing. The difference between groups approached significance but fell short of the standard threshold used in research. This suggests that while starting bone density matters, it’s not a perfect predictor on its own.
The study examined whether any combination of blood markers together could predict bone changes, but no combination proved useful. The researchers also looked at whether the rate of bone loss differed between groups based on various blood markers, but again found no significant patterns. These negative findings are actually important because they tell doctors that relying on blood tests alone to forecast bone health changes may not be reliable.
Previous research has suggested that certain blood markers related to bone turnover (the process of old bone breaking down and new bone forming) might predict bone loss. This study challenges that assumption by showing that in real clinical practice, these markers don’t reliably predict who will develop osteoporosis. The findings suggest that the relationship between blood markers and bone health may be more complex than laboratory studies suggest, or that other unmeasured factors play a larger role.
The researchers were honest about the study’s limitations. First, they didn’t have information about whether patients were taking medications to prevent bone loss, which could significantly affect bone density changes. Second, they lacked complete data on menopausal status for women, an important factor in bone health. Third, the study only included patients from one hospital in Saudi Arabia, so results may not apply to other countries or populations. Fourth, because this was a retrospective study using old medical records, the researchers couldn’t control for all factors that might influence bone health. Finally, the study period was relatively short (2016 to 2021), which might not be long enough to see all the changes in bone density that occur over a lifetime.
The Bottom Line
Based on this research, doctors should not rely on routine blood tests alone to predict bone loss or osteoporosis development. Instead, bone density scans (DXA scans) remain the best tool for assessing bone health and predicting progression. If you have concerns about bone health, discuss with your doctor about getting a bone density scan rather than relying on blood test results. The confidence level for this recommendation is high because the study tested 20 different markers and found none to be useful.
This research matters for anyone concerned about bone health, especially women approaching or past menopause, older adults, and people with family histories of osteoporosis. It’s particularly relevant for doctors and healthcare systems trying to decide which tests to order. However, the findings don’t change recommendations for bone density screening itself, which remains important for identifying people at risk.
Changes in bone density happen slowly over months and years. If you’re concerned about bone loss, expect to wait at least one to two years between bone density scans to see meaningful changes. Blood tests won’t help predict these changes in the short term based on this research.
Frequently Asked Questions
Can blood tests predict if I will develop osteoporosis?
No, according to a 2026 study of over 2,000 patients, routine blood tests cannot reliably predict osteoporosis development. Bone density scans (DXA scans) are more useful for assessing bone health and identifying risk. Talk to your doctor about screening recommendations based on your age and risk factors.
What blood markers were tested for predicting bone loss?
The study tested 20 different blood markers, but the specific markers weren’t detailed in the abstract. These likely included bone turnover markers that show how quickly bone is breaking down and reforming. None of these markers proved useful for predicting who would develop osteoporosis in this patient population.
How often should I get bone density scans if I’m at risk for osteoporosis?
The study doesn’t specify screening intervals, but standard medical guidelines typically recommend bone density scans every one to two years for people at risk. Your doctor can recommend the right timing based on your age, sex, family history, and other risk factors. Scans are more reliable than blood tests for tracking bone health.
Does this study mean blood tests are useless for bone health?
Not entirely. Blood tests can measure calcium, vitamin D, and other nutrients important for bone health. However, this study shows they cannot predict who will develop osteoporosis. Blood tests remain useful for identifying nutritional deficiencies that affect bones, but they shouldn’t be relied upon alone for predicting bone loss.
Why couldn’t blood tests predict bone loss in this study?
The researchers didn’t have complete information about medications patients were taking or other factors affecting bone health. The relationship between blood markers and actual bone loss may be more complex than expected. They recommend future studies with better tracking of treatments and repeated measurements over longer periods.
Want to Apply This Research?
- Track your bone density scan results over time, recording the T-score (the number that indicates bone strength) from each scan. Note the date of each scan and any changes in the score. This direct measurement is more useful than tracking blood test results for predicting bone health changes.
- Use the app to set reminders for bone density screening appointments based on your doctor’s recommendations, typically every one to two years for people at risk. Record lifestyle factors known to affect bone health, such as calcium intake, vitamin D exposure, exercise frequency, and any bone-strengthening medications you take.
- Create a long-term tracking system that compares bone density scores across multiple years. Set up alerts when it’s time for your next screening. Keep a log of any symptoms like back pain or height loss that might indicate bone problems. Share this information with your healthcare provider to guide treatment decisions.
This research shows that routine blood tests cannot reliably predict osteoporosis development in clinical practice. However, this does not mean blood tests are useless for bone health assessment. Blood tests can identify nutritional deficiencies and other conditions affecting bones. If you have concerns about bone health, osteoporosis risk, or bone loss, consult with your healthcare provider about appropriate screening with bone density scans and other evaluations. This article summarizes research findings and should not be interpreted as medical advice. Individual bone health assessment requires evaluation by a qualified healthcare professional who knows your complete medical history.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.